A Novel Homozygous Mutation of Thyroid Peroxidase Gene Abolishes a Disulfide Bond Leading to Congenital Hypothyroidism

Abstract EN

Congenital hypothyroidism (CH) is the most prevalent congenital endocrine disorder and causes mental retardation.

A male Japanese patient with first cousin marriage parents was diagnosed as CH at 10 months.

He was born before introduction of mass screening for CH.

With continuous thyroid hormone replacement therapy, normal thyroid hormone status was maintained until adulthood.

Genetic screening of next-generation sequencing was performed at the age of 52 years, and we identified a new homozygous thyroid peroxidase (TPO) gene mutation (GRCh38.p13, chromosome 2 at position 1493997, c.1964 G>T, p.Cys655Phe).

TPO is an important enzyme to produce thyroid hormone.

As demonstrated by a homology analysis of TPO proteins among different species, cysteine 655 residue is highly conserved, suggesting an important role in maintaining TPO function and structure.

An in silico study with three-dimensional structure of the novel mutation was performed and suggested that the mutation abolished disulfide bond between cysteines at positions 598 and 655.

An in vitro functional analysis using HEK293 cells revealed that TPO activity of the mutant was significantly impaired compared with that of the wild type.

Furthermore, study of immunohistochemistry showed that localization of TPO in cells did not differ between the wild type and the mutant.

In conclusion, this single disulfide bond loss mutation of a new TPO homozygous mutation, p.Cys655Phe, reduced TPO activity and caused congenital hypothyroidism without affecting subcellular localization of TPO proteins.